School of Medicine Homepage
Emory University Shield
  • About
    • Our Vision
    • Academic Departments
    • Our Leadership
    • Health Care Partnerships
    • Diversity, Equity, & Inclusion
    • Location
    • Supporting Our People
    • Our Faculty
    • History
    • News
    • Events
    • Contact Us
  • Education
    • Degree and Certificate Programs
    • Academic Departments
    • Residents & Fellows
    • Postdoctoral Training
    • Continuing Medical Education
    • Admissions
    • Cost and Financial Aid
    • Student Resources
  • Research
    • Research Innovation
    • Conducting Research
    • Core Facilities
    • Research Centers
    • Research Training
    • Academic Departments
    • Find a Researcher
    • Research News
  • Clinical Experience
    • Where We Work
    • Caring for a Diverse Population
    • Faculty Clinical Experience
    • Advanced Patient Care
    • Academic Departments
    • Community Learning
  • Giving
  • Directory

Directory section navigation

  • Faculty Profiles

Emory University School of Medicine

  • About
    • Sub link
      Our Vision
    • Sub link
      Academic Departments
    • Sub link
      Our Leadership
    • Sub link
      Health Care Partnerships
    • Sub link
      Diversity, Equity, & Inclusion
    • Sub link
      Location
    • Sub link
      Supporting Our People
    • Sub link
      Our Faculty
    • Sub link
      History
    • Sub link
      News
    • Sub link
      Events
    • Sub link
      Contact Us
  • Education
    • Sub link
      Degree and Certificate Programs
    • Sub link
      Academic Departments
    • Sub link
      Residents & Fellows
    • Sub link
      Postdoctoral Training
    • Sub link
      Continuing Medical Education
    • Sub link
      Admissions
    • Sub link
      Cost and Financial Aid
    • Sub link
      Student Resources
  • Research
    • Sub link
      Research Innovation
    • Sub link
      Conducting Research
    • Sub link
      Core Facilities
    • Sub link
      Research Centers
    • Sub link
      Research Training
    • Sub link
      Academic Departments
    • Sub link
      Find a Researcher
    • Sub link
      Research News
  • Clinical Experience
    • Sub link
      Where We Work
    • Sub link
      Caring for a Diverse Population
    • Sub link
      Faculty Clinical Experience
    • Sub link
      Advanced Patient Care
    • Sub link
      Academic Departments
    • Sub link
      Community Learning
  • Giving
  • Directory
  • Home School of Medicine Home
  • Directory

Profile

Kenneth Ogan MD

  • Department of Urology
    Professor
  • (404) 778-3038
Head shot of Kenneth Ogan

Overview

Dr. Ogan is the Louis McDonald Orr Clinical Professor of Urology at the Emory University School of Medicine and Associate Chief of Urology at Emory University Hospital.

Dr. Ogan attended the University of Vermont, Burlington, VT for his undergraduate education (Bachelor in Art). He received his medical degree from New York Medical College in Valhalla, New York followed by urology residency training at George Washington University School of Medicine. Dr. Ogan completed his fellowship training in endourology, minimally invasive surgery and laparoscopy at the University of Texas Southwestern Medical Center in Dallas, Texas. Dr. Ogan is a diplomate of the American Board of Urology (2003).

Dr. Ogan clinical and research interests lie in minimally invasive therapy including laparoscopic and robotic urologic oncologic (cancer) surgery. He has pioneered various surgical techniques for laparoscopic, robotic and thermal ablation kidney cancer surgery to cure patients from cancer while preserving their kidney function. Dr. Ogan performs robotic surgery for the treatment of kidney, bladder and prostate cancer. Patients attending Emory Urology for cancer treatment have the unique opportunity to be cured of their disease while at the same time preserve their vital organs, their functionality and quality of life. As co-director of the Stone Clinic, Dr. Ogan is also involved in the prevention and endoscopic/percutaneous management of patients with kidney stones.

Dr. Ogan has lectured both nationally and internationally. He is closely involved in teaching and mentoring medical students, urology residents and post-graduate fellows. His research involves the utilization of innovative virtual reality systems to train surgeons to perform surgical procedures. Dr. Ogans innovative work in teaching and training surgeons is well recognized nationally. He is the recipient of the Golden Apple Teaching Award from Emory University Department of Urology in 2008 & 2012. He has authored multiple book chapters and scientific journal articles.

Academic Appointment

  • Louis McDonald Orr Clinical Professor Of Urology, Emory University School of Medicine
  • Professor, Department of Urology, Emory University School of Medicine

Education

Degrees

  • MD from New York Medical College
  • BA from University of Vermont

Research

Focus

  • My clinical and laboratory efforts have been involved with the minimally invasive treatment of urological diseases. Specifically, I have worked on developing techniques for laparoscopic partial nephrectomy and ablation of small renal tumors. I am also interested in the prevention and endoscopic/percutaneous treatment of kidney stones. Additionally, I have done research on virtual reality systems and training residents to perform urological surgeries.

Publications

  • Incidence of New Mental Health Diagnosis in Testicular Cancer Survivors.
    Urology Volume: 200 Page(s): 135 - 141
    06/01/2025 Authors: Marthi S; Palmateer G; Helman T; Patil D; Nicaise E; Goodstein T; Ogan K; Narayan V; Master V; Joshi SS
  • Neoadjuvant cabozantinib for locally advanced nonmetastatic clear cell renal cell carcinoma: a phase 2 trial.
    Nat Cancer Volume: 6 Page(s): 432 - 444
    03/01/2025 Authors: Bilen MA; Vo BT; Liu Y; Greenwald R; Davarpanah AH; McGuire D; Shiradkar R; Li L; Midya A; Nazha B
  • Paraneoplastic Syndrome Prevalence and Survival in Racially-Diverse Cohort With Renal Cell Carcinoma.
    Clin Genitourin Cancer Volume: 22 Page(s): 102207
    12/01/2024 Authors: Nicaise EH; Schmeusser BN; Palmateer G; Vashi K; Parikh K; Patil D; Shapiro DD; Abel EJ; Joshi S; Narayan V
  • The diagnostic challenges of differentiating metastatic extramammary Paget disease and prostatic adenocarcinoma: A case report and review of the literature.
    Urol Case Rep Volume: 57 Page(s): 102875
    11/01/2024 Authors: Palmateer G; Nicaise EH; Gandhi J; Goodstein T; Sheng M; Ogan K; Kucuk O; Yushak M; Sanda MG; Delman KA
  • PD-L1 and nectin-4 expression and genomic characterization of bladder cancer with divergent differentiation.
    Cancer Volume: 130 Page(s): 3658 - 3670
    11/01/2024 Authors: Martini DJ; Case KB; Gratz D; Pellegrini K; Beagle E; Schneider T; Dababneh M; Nazha B; Brown JT; Joshi SS
  • Paraneoplastic Resolution Holds Prognostic Utility in Patients with Metastatic Renal Cell Carcinoma.
    Cancers (Basel) Volume: 16
    10/30/2024 Authors: Palmateer G; Nicaise EH; Goodstein T; Schmeusser BN; Patil D; Imtiaz N; Shapiro DD; Abel EJ; Joshi S; Narayan V
  • Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 study.
    Lancet Oncol Volume: 25 Page(s): 1038 - 1052
    08/01/2024 Authors: Allaf ME; Kim S-E; Master V; McDermott DF; Harshman LC; Cole SM; Drake CG; Signoretti S; Akgul M; Baniak N
  • Linear Muscle Segmentation for Metastatic Renal Cell Carcinoma: Changes in Clinic-Friendly Estimation Predict Survival Following Cytoreductive Nephrectomy.
    Clin Genitourin Cancer Volume: 22 Page(s): 102056
    06/01/2024 Authors: Nicaise EH; Schmeusser BN; Ali A; Midenberg E; Palacios AR; Hartsoe B; Kearns E; Ambadi S; Patil DH; Joshi SS
  • Differences in preoperative frailty assessment of surgical candidates by sex, age, and race.
    Surg Open Sci Volume: 19 Page(s): 172 - 177
    06/01/2024 Authors: Nicaise EH; Palmateer G; Schmeusser BN; Futral C; Liu Y; Goyal S; Nabavizadeh R; Kooby DA; Maithel SK; Sweeney JF
  • A missense SNP in the tumor suppressor SETD2 reduces H3K36me3 and mitotic spindle integrity in Drosophila.
    Genetics Volume: 226
    04/03/2024 Authors: Brockett JS; Manalo T; Zein-Sabatto H; Lee J; Fang J; Chu P; Feng H; Patil D; Davidson P; Ogan K
  • 2018 Leibovich prognostic model for renal cell carcinoma: Performance in a large population with special consideration of Black race.
    Cancer Volume: 130 Page(s): 453 - 466
    02/01/2024 Authors: Schmeusser BN; Patil DH; Nicaise EH; Armas-Phan M; Nabavizadeh R; Narayan VM; Joshi SS; Ogan K; Osunkoya AO; Bilen MA
  • AUTHOR REPLY.
    Urology Volume: 183 Page(s): 155 - 156
    01/01/2024 Authors: Schmeusser BN; Nicaise EH; Ogan K; Master VA
  • Performance of Future Glomerular Filtration Rate Equation by Race in a Large, Racially Diverse Patient Cohort Undergoing Nephrectomy for Renal Cell Carcinoma.
    Urology Volume: 183 Page(s): 147 - 156
    01/01/2024 Authors: Schmeusser BN; Nicaise EH; Palacios AR; Ali A; Patil DH; Armas-Phan M; Ogan K; Master VA
  • Cytoreductive surgery, systemic treatment, genetic evaluation, and patient perspective in a young adult with metastatic renal cell carcinoma.
    CA Cancer J Clin Volume: 74 Page(s): 323 - 338
    01/01/2024 Authors: Nicaise EH; Yildirim A; Sheth S; Richter E; Daneshmand MA; Maithel SK; Ogan K; Bilen MA; Master VA
  • Immune-Related Adverse Events and Clinical Outcomes in Advanced Urothelial Cancer Patients Treated With Immune Checkpoint Inhibitors.
    Oncologist Volume: 28 Page(s): 1072 - 1078
    12/11/2023 Authors: Sanda GE; Shabto JM; Goyal S; Liu Y; Martini DJ; Nazha B; Brown JT; Yantorni LB; Anne Russler G; Caulfield S
  • Creatinine to Cystatin-C Ratio in Renal Cell Carcinoma: A Clinically Pragmatic Prognostic Factor and Sarcopenia Biomarker.
    Oncologist Volume: 28 Page(s): e1219 - e1229
    12/11/2023 Authors: Schmeusser BN; Biermann H; Nicaise EH; Ali AA; Patil DH; Midenberg E; Helman T; Armas-Phan M; Nabavizadeh R; Joshi SS
  • Evaluation of a Non-race-based Equation in Predicting Glomerular Filtration Rates Postnephrectomy in a Racially Diverse Cohort.
    Urol Pract Volume: 10 Page(s): 547 - 550
    11/01/2023 Authors: Nicaise EH; Schmeusser BN; Patil DH; Ogan K; Master VA
  • Reply by Authors.
    Urol Pract Volume: 10 Page(s): 552
    11/01/2023 Authors: Nicaise EH; Schmeusser BN; Patil DH; Ogan K; Master VA
  • Diagnostic Performance and Safety of Positron Emission Tomography with 18F-rhPSMA-7.3 in Patients with Newly Diagnosed Unfavourable Intermediate- to Very-high-risk Prostate Cancer: Results from a Phase 3, Prospective, Multicentre Study (LIGHTHOUSE).
    Eur Urol Volume: 84 Page(s): 361 - 370
    10/01/2023 Authors: Surasi DS; Eiber M; Maurer T; Preston MA; Helfand BT; Josephson D; Tewari AK; Somford DM; Rais-Bahrami S; Koontz BF
  • Low Skeletal Muscle as a Risk Factor for Worse Survival in Nonmetastatic Renal Cell Carcinoma with Venous Tumor Thrombus.
    Clin Genitourin Cancer Volume: 21 Page(s): 475 - 482.e4
    08/01/2023 Authors: Schmeusser BN; Midenberg E; Palacios AR; Ali AA; Patil DH; Higgins M; Nabavizadeh R; Croll B; Williams M; Sheehy J
  • Barriers and facilitators to physical activity prehabilitation in patients with kidney cancer.
    Eur J Oncol Nurs Volume: 65 Page(s): 102333
    08/01/2023 Authors: Paulo CM; Ali AA; Schmeusser BN; Midenberg E; Helman TA; Diller ML; Pisters MF; Ogan K; Master VA
  • Reply to Pankaj N. Maheshwari, Aditya Goal, and Pushkar Srivastava's Letter to the Editor re: Manuel Armas-Phan, Benjamin N. Schmeusser, Nicholas W. Eyrich, and Kenneth Ogan. Double-J Stent Misplacement in the Inferior Vena Cava and Right Atrium: A Urovascular Nightmare. Eur Urol Open Sci 2022;46:128-34.
    Eur Urol Open Sci Volume: 50 Page(s): 24 - 25
    04/01/2023 Authors: Schmeusser BN; Armas-Phan M; Eyrich NW; Ogan K
  • IMPLICATIONS OF RACE FREE RENAL FUNCTION EQUATIONS ON BLACK PATIENTS WITH RENAL CELL CARCINOMA
    Volume: 209 Page(s): E133 - E134
    04/01/2023 Authors: Schmeusser BN; Palacios AR; Midenberg E; Nabavizadeh R; Ali A; Patil DH; Harvey RD; Bryksin J; Connor MJ; Ogan K
  • Race-free renal function estimation equations and potential impact on Black patients: Implications for cancer clinical trial enrollment.
    Cancer Volume: 129 Page(s): 920 - 924
    03/15/2023 Authors: Schmeusser BN; Palacios AR; Midenberg ER; Nabavizadeh R; Patil DH; Harvey RD; Bryksin J; Connor MJ; Ogan K; Bilen MA
  • Effect of race-free estimated glomerular filtration rate equations (eGFR) on oncology clinical trial eligibility for Black patients.
    Volume: 41
    02/20/2023 Authors: Schmeusser B; Palacios AR; Midenberg E; Nabavizadeh R; Patil DH; Harvey RD; Bryksin J; Connor MJ; Ogan K; Bilen MA
  • Creatinine to cystatin C ratio and mortality in renal cell carcinoma.
    Volume: 41
    02/20/2023 Authors: Schmeusser B; Ali A; Patil DH; Midenberg E; Nabavizadeh R; Ogan K; Master VA
  • Validating the Palacios' future glomerular filtration rate equation with and without race.
    Volume: 41
    02/20/2023 Authors: Schmeusser B; Ali A; Patil DH; Palacios AR; Armas-Phan M; Ogan K; Master VA
  • Association of inflammation and depression in renal cell carcinoma.
    Volume: 41
    02/20/2023 Authors: Schmeusser B; Ali A; Patil DH; Midenberg E; Petrinec B; Bilen MA; Ogan K; Master VA
  • Neoadjuvant Nivolumab and Ipilimumab for Nonmetastatic Renal Cell Carcinoma with Tumor Thrombus.
    J Immunother Precis Oncol Volume: 6 Page(s): 50 - 55
    02/01/2023 Authors: Master VA; Schmeusser BN; Osunkoya AO; Palacios AR; Midenberg E; Yantorni L; Ogan K; Bilen MA
  • Prognostic Value of Sarcopenia and Albumin in the Surgical Management of Localized Renal Cell Carcinoma.
    Urol Oncol Volume: 41 Page(s): 50.e19 - 50.e26
    01/01/2023 Authors: Midenberg E; Higgins MI; Schmeusser BN; Patil DH; Zaldumbide J; Martini DJ; Steele S; Williams M; Nabavizadeh R; Psutka SP
  • Mayo Adhesive Probability Score Does Not Have Prognostic Ability in Locally Advanced Renal Cell Carcinoma.
    J Kidney Cancer VHL Volume: 10 Page(s): 19 - 25
    01/01/2023 Authors: Schmeusser BN; Manalo TA; Liu Y; Shah YB; Ali A; Armas-Phan M; Patil DH; Nabavizadeh R; Ogan K; Master VA
  • Resection of retroperitoneal tumors with inferior vena cava involvement without caval reconstruction.
    J Surg Oncol Volume: 126 Page(s): 1306 - 1315
    12/01/2022 Authors: Palacios AR; Schmeusser BN; Midenberg E; Patil D; Xie L; Nabavizadeh R; Ogan K; Cardona K; Maithel SK; Master VA
  • Data regarding covariates significantly associated with sarcopenia and varying albumin statuses in patients with renal cell carcinoma.
    Data Brief Volume: 45 Page(s): 108724
    12/01/2022 Authors: Schmeusser BN; Patil DH; Midenberg E; Higgins MI; Zaldumbide J; Martini DJ; Steele S; Williams M; Nabavizadeh R; Psutka SP
  • Double-J Stent Misplacement in the Inferior Vena Cava and Right Atrium: A Urovascular Nightmare.
    Eur Urol Open Sci Volume: 46 Page(s): 128 - 134
    12/01/2022 Authors: Armas-Phan M; Schmeusser BN; Eyrich NW; Ogan K
  • Association of grit and overall survival in patients undergoing nephrectomy for renal cell carcinoma.
    Transl Androl Urol Volume: 11 Page(s): 1503 - 1511
    11/01/2022 Authors: Midenberg ER; Schmeusser BN; Palacios A; Larsen K; Patil DH; Petrinec B; Croll B; Le T-L; Hong G; Lin FR
  • Sarcopenia and systemic inflammation are associated with decreased survival after cytoreductive nephrectomy for metastatic renal cell carcinoma.
    Cancer Volume: 128 Page(s): 2073 - 2084
    06/01/2022 Authors: Khan AI; Psutka SP; Patil DH; Hong G; Williams MA; Bilen MA; Sekhar A; Kissick HT; Narayan VM; Joshi SS
  • RENAL FUNCTIONAL CHANGES AFTER CYSTECTOMY: WHO IMPROVES AND WHO DOES NOT?
    Volume: 207 Page(s): E971 - E971
    05/01/2022 Authors: Croll B; Patil D; Vashi K; Alemozaffar M; Master V; Filson C; Ogan K; Narayan V; Joshi S
  • Low free testosterone is associated with increased mortality in frail surgical patients.
    Surg Open Sci Volume: 7 Page(s): 36 - 41
    01/01/2022 Authors: Lin F; Hong G; Kwon F; Pirani F; Makhani S; Henry M; Cooke I; Nabavizadeh R; Midenberg E; Mehta A
  • Clinic friendly estimation of muscle composition: Preoperative linear segmentation shows overall survival correlated with muscle mass in patients with nonmetastatic renal cell carcinoma.
    Front Oncol Volume: 12 Page(s): 1068357
    01/01/2022 Authors: Schmeusser BN; Midenberg E; Palacios AR; Vettikattu N; Patil DH; Medline A; Higgins M; Armas-Phan M; Nabavizadeh R; Joshi SS
  • Urine-Based Metabolomics and Machine Learning Reveals Metabolites Associated with Renal Cell Carcinoma Stage.
    Cancers (Basel) Volume: 13
    12/13/2021 Authors: Bifarin OO; Gaul DA; Sah S; Arnold RS; Ogan K; Master VA; Roberts DL; Bergquist SH; Petros JA; Edison AS
  • Body Composition as an Independent Predictive and Prognostic Biomarker in Advanced Urothelial Carcinoma Patients Treated with Immune Checkpoint Inhibitors.
    Oncologist Volume: 26 Page(s): 1017 - 1025
    12/01/2021 Authors: Martini DJ; Shabto JM; Goyal S; Liu Y; Olsen TA; Evans ST; Magod BL; Ravindranathan D; Brown JT; Yantorni L
  • Using Cystatin C and Serum Creatinine to Predict Renal Volume Post-nephrectomy
    Volume: 233 Page(s): E229 - E229
    11/01/2021 Authors: Petrinec B; Cooke I; Midenburg E; Ogan K; Master V
  • Small-Cell Carcinoma of the Prostate: Report of Outcomes of Localized Disease Using the National Cancer Database.
    Clin Genitourin Cancer Volume: 19 Page(s): e193 - e199
    08/01/2021 Authors: Xu KM; Liu Y; Gillespie TW; Osunkoya AO; Carthon B; Bilen MA; Filson CP; Ogan K; Patel PR; Shelton JW
  • Machine Learning-Enabled Renal Cell Carcinoma Status Prediction Using Multiplatform Urine-Based Metabolomics.
    J Proteome Res Volume: 20 Page(s): 3629 - 3641
    07/02/2021 Authors: Bifarin OO; Gaul DA; Sah S; Arnold RS; Ogan K; Master VA; Roberts DL; Bergquist SH; Petros JA; Fernndez FM
  • A Helpful Tool in the Renal Surgery Armamentarium: Dorsal Lumbotomy nephrectomy for Tumor in Patients with End-Stage Renal Disease.
    Urology Volume: 153 Page(s): 327 - 332
    07/01/2021 Authors: Cooke I; Sadruddin S; Patil D; Tripathi S; Nabavizadeh R; Joshi S; Narayan V; Ogan K; Master VA
  • Modified Glasgow Prognostic Score associated with survival in metastatic renal cell carcinoma treated with immune checkpoint inhibitors.
    J Immunother Cancer Volume: 9
    07/01/2021 Authors: Brown JT; Liu Y; Shabto JM; Martini D; Ravindranathan D; Hitron EE; Russler GA; Caulfield S; Yantorni L; Joshi SS
  • Prospective Randomized Trial Comparing the Safety and Clarity of Water Versus Saline Irrigant in Ureteroscopy.
    Eur Urol Focus Volume: 7 Page(s): 850 - 856
    07/01/2021 Authors: Pirani F; Makhani SS; Kim FY; Lay AH; Cimmino CB; Hartsell L; Spence A; Master VA; Ogan K
  • Sarcopenia and modified Glasgow Prognostic Score predict postsurgical outcomes in localized renal cell carcinoma.
    Cancer Volume: 127 Page(s): 1974 - 1983
    06/15/2021 Authors: Higgins MI; Martini DJ; Patil DH; Nabavizadeh R; Steele S; Williams M; Joshi SS; Narayan VM; Sekhar A; Psutka SP
  • Reply to Eugenio Ventimiglia, Steeve Doizi, Andrea Salonia, and Olivier Traxer's Letter to the Editor re: Farha Pirani, Salima S. Makhani, Frances Y. Kim, et al. Prospective Randomized Trial Comparing the Safety and Clarity of Water Versus Saline Irrigant in Ureteroscopy. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2020.02.009.
    Eur Urol Focus Volume: 7 Page(s): 666 - 667
    05/01/2021 Authors: Pirani F; Makhani S; Kim F; Lay A; Cimmino C; Hartsell L; Spence A; Master VA; Ogan K
  • Baseline Modified Glasgow Prognostic Score Associated with Survival in Metastatic Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors.
    Oncologist Volume: 26 Page(s): 397 - 405
    05/01/2021 Authors: Brown JT; Liu Y; Shabto JM; Martini DJ; Ravindranathan D; Hitron EE; Russler GA; Caulfield S; Yantorni LB; Joshi SS
  • Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos.
    J Vis Exp
    03/21/2021 Authors: Steele S; Lin F; Le T-L; Medline A; Higgins M; Sandberg A; Evans S; Hong G; Williams MA; Bilen MA
  • Outcomes in Patients with Renal Cell Carcinoma Undergoing Inferior Vena Cava Ligation without Reconstruction versus Thrombectomy: A Retrospective, Case Controlled Study.
    J Urol Volume: 205 Page(s): 383 - 391
    02/01/2021 Authors: Xie L; Hong G; Nabavizadeh R; Patil D; Ethun CG; Ogan K; Maithel SK; Master VA
  • Overlapping Urological Surgeries at a Tertiary Academic Center.
    Urology Volume: 148 Page(s): 118 - 125
    02/01/2021 Authors: Nabavizadeh R; Higgins MI; Patil D; Biebighauser Bens KC; Traor E; Master VA; Ogan K
  • EDITORIAL COMMENT.
    Urology Volume: 148 Page(s): 124 - 125
    02/01/2021 Authors: Nabavizadeh R; Higgins MI; Master VA; Ogan K
  • Transplant Radical Nephrectomy and Transplant Radical Nephroureterectomy for Renal Cancer: Postoperative and Survival Outcomes.
    Ann Transplant Volume: 25 Page(s): e925865
    10/23/2020 Authors: Nabavizadeh R; Noorali AA; Makhani SS; Hong G; Holzman S; Patil DH; Kim FY; Tso PL; Turgeon NA; Ogan K
  • Sarcopenia and Neutrophil-Lymphocyte Ratio Are Associated with Overall Survival after Surgery for Localized Renal Cell Carcinoma
    Volume: 231 Page(s): S339 - S339
    10/01/2020 Authors: Higgins M; Nabavizadeh R; Patil DH; Ogan K; Kissick H; Bilen MA; Master V
  • International, Multi-Institutional Study of 1330 Patients Evaluating the Dynamic Evaluation of the Modified Glasgow Prognostic Scale in Patients with Renal Cell Carcinoma
    Volume: 231 Page(s): S338 - S339
    10/01/2020 Authors: Nabavizadeh R; Patil DH; Medline A; Fukuda S; Yasuda Y; Ogan K; Master V
  • Re: Prospective Randomized Trial Comparing the Safety and Clarity of Water versus Saline Irrigant in Ureteroscopy.
    J Urol Volume: 204 Page(s): 874
    10/01/2020 Authors: Assimos DG
  • Molecular characteristics and markers of advanced clear cell renal cell carcinoma: Pitfalls due to intratumoral heterogeneity and identification of genetic alterations associated with metastasis.
    Int J Urol Volume: 27 Page(s): 790 - 797
    09/01/2020 Authors: Obeng RC; Arnold RS; Ogan K; Master VA; Pattaras JG; Petros JA; Osunkoya AO
  • Dynamic Evaluation of the Modified Glasgow Prognostic Scale in Patients With Resected, Localized Clear Cell Renal Cell Carcinoma.
    Volume: 141 Page(s): 101 - 107
    07/01/2020 Authors: Patil D; Le T-L; Bens KB; Alemozaffar M; Lay A; Pattaras J; Filson CP; Ogan K; Bilen MA; Master VA
  • LOW FREE TESTOSTERONE AND FRAILTY PREDICT OVERALL SURVIVAL IN SURGICAL PATIENTS
    Volume: 203 Page(s): E859 - E859
    04/01/2020 Authors: Lin F; Hong G; Kim F; Pirani F; Makhani S; Henry M; Cooke I; Nabavizadeh R; Ritenour CWM; Alemozaffar M
  • LONG-TERM FUNCTIONAL OUTCOMES OF INFERIOR VENA CAVA RESECTION COMPARED TO THROMBECTOMY IN RENAL CELL CARCINOMA PATIENTS: A RETROSPECTIVE, CASE-CONTROLLED STUDY
    Volume: 203 Page(s): E1004 - E1004
    04/01/2020 Authors: Xie L; Hong G; Patil D; Nabavizadeh R; Lin F; Ethun CG; Maithel SK; Cardona K; Ogan K; Master VA
  • Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors.
    Cancer Med Volume: 9 Page(s): 2752 - 2760
    04/01/2020 Authors: Shabto JM; Martini DJ; Liu Y; Ravindranathan D; Brown J; Hitron EE; Russler GA; Caulfield S; Kissick H; Alemozaffar M
  • Association of baseline modified Glasgow Prognostic Score (mGPS) with survival outcomes in patients with metastatic urothelial cell carcinoma (mUCC) treated with immune checkpoint inhibitors (CPI)
    Volume: 38
    02/20/2020 Authors: Brown JT; Liu Y; Shabto JM; Martini DJ; Ravindranathan D; Hitron E; Russler G; Caulfield S; Yantorni LB; Joshi SS
  • Association of modified Glasgow Prognostic Score (mGPS) with survival outcomes in patients with metastatic renal cell carcinoma (mRCC) treated with immune checkpoint inhibitors (CPI)
    Volume: 38
    02/20/2020 Authors: Brown JT; Liu Y; Martini DJ; Shabto JM; Hitron E; Russler G; Caulfield S; Yantorni LB; Joshi SS; Kissick H
  • Variation in Estimated Glomerular Filtration Rate Values Before Nephrectomy Based on Cystatin C, Chronic Kidney Disease Epidemiology Collaboration, Cockcroft-Gault, and Modification of Diet in Renal Disease Formulas
    Volume: 229 Page(s): S323 - S323
    10/01/2019 Authors: Hong G; Henry M; Pirani F; Patil D; Ogan K; Connor M; Bilen MA; Harvey RD; Bryksin J; Master V
  • Outcomes in Renal Cell Carcinoma Patients Undergoing IVC Ligation vs Thrombectomy: A Retrospective, Case-Controlled Study
    Volume: 229 Page(s): S318 - S319
    10/01/2019 Authors: Xie L; Hong G; Patil D; Nabavizadeh R; Ethun CG; Maithel SK; Cardona K; Ogan K; Master VA
  • A randomized, controlled trial for transurethral treatment of bladder tumors using PlasmaButton vaporization electrode or monopolar loop electrocautery.
    Can J Urol Volume: 26 Page(s): 9908 - 9915
    10/01/2019 Authors: Alemozaffar M; Ogan K; Filson CP; Patil D; Lee G; Canter DJ; Hong G; Master VA
  • MRI quantitation of abdominal skeletal muscle correlates with CT-based analysis: implications for sarcopenia measurement.
    Appl Physiol Nutr Metab Volume: 44 Page(s): 814 - 819
    08/01/2019 Authors: Khan AI; Reiter DA; Sekhar A; Sharma P; Safdar NM; Patil DH; Psutka SP; Small WC; Bilen MA; Ogan K
  • RATE OF OPIOID PRESCRIPTION REFILLING FOLLOWING UROLOGIC STONE SURGERY
    Volume: 201 Page(s): E325 - E325
    04/01/2019 Authors: Said M; Ismaeel N; Patil D; Ogan K; Mehta A; Filson C; Lay A
  • RISK OF PROLONGED OPIOID USE AMONG OPIOID-NAIVE PATIENTS FOLLOWING UROLOGIC STONE SURGERY
    Volume: 201 Page(s): E325 - E325
    04/01/2019 Authors: Said M; Leung A; Patil D; Ogan K; Mehta A; Filson C; Lay A
  • RISK OF PROLONGED OPIOID USE AMONG OPIOID-NAIVE PATIENTS FOLLOWING UROLOGIC-MINIMALLY INVASIVE SURGERY
    Volume: 201 Page(s): E197 - E197
    04/01/2019 Authors: Said M; Patil D; Ogan K; Mehta A; Filson C; Lay A
  • Analysis of toxicity and clinical outcomes (CO) in full versus reduced dose cabozantinib (cabo) in metastatic renal cell carcinoma (mRCC) patients (pts).
    Volume: 37
    03/01/2019 Authors: Martini DJ; Shabto JM; Liu Y; Carthon BC; Speak A; Hitron E; Russler G; Caulfield S; Ogan K; Harris W
  • Association of inflammation and clinical outcomes (CO) in metastatic renal cell carcinoma (mRCC) patients (pts) treated with cabozantinib (cabo).
    Volume: 37
    03/01/2019 Authors: Martini DJ; Shabto JM; Liu Y; Carthon BC; Speak A; Hitron E; Russler G; Caulfield S; Ogan K; Harris W
  • Sites of metastases (mets) and their association with clinical outcomes (CO) in urothelial cancer patients (pts) treated with immunotherapy (IO).
    Volume: 37
    03/01/2019 Authors: Shabto JM; Martini DJ; Liu Y; Ravindranathan D; Kline MR; Hitron E; Russler G; Caulfield S; Kissick H; Alemozaffar M
  • Association between immune-related adverse events (irAEs) and clinical outcomes (CO) in advanced urothelial cancer patients (pts) treated with immunotherapy (IO).
    Volume: 37
    03/01/2019 Authors: Shabto JM; Martini DJ; Liu Y; Ravindranathan D; Kline MR; Hitron E; Russler G; Caulfield S; Kissick H; Alemozaffar M
  • Sarcopenia is independently associated with decreased overall survival after surgery for inferior vena cava tumor thrombus patients.
    Volume: 37
    03/01/2019 Authors: Williams M; Nabavizadeh R; Khan AI; Patil DH; Psutka SP; Sekhar A; Ogan K; Bilen MA; Master VA
  • Sites of metastasis (mets) and association with clinical outcomes (CO) in metastatic renal cell carcinoma (mRCC) patients (pts) treated with cabozantinib (cabo).
    Volume: 37
    03/01/2019 Authors: Martini DJ; Shabto JM; Liu Y; Carthon BC; Speak A; Hitron E; Russler G; Caulfield S; Ogan K; Harris W
  • Body mass index (BMI) and toxicities and association with clinical outcomes (CO) in metastatic renal cell carcinoma (mRCC) patients (pts) treated with cabozantinib (cabo).
    Volume: 37
    03/01/2019 Authors: Martini DJ; Shabto JM; Liu Y; Carthon BC; Speak A; Hitron E; Russler G; Caulfield S; Ogan K; Harris W
  • Inflammatory markers at baseline (C1) and cycle 3 (C3) and their association with clinical outcomes in urothelial cancer patients (pts) treated with immunotherapy (IO).
    Volume: 37
    03/01/2019 Authors: Shabto JM; Martini DJ; Liu Y; Ravindranathan D; Kline MR; Hitron E; Russler G; Caulfield S; Kissick H; Alemozaffar M
  • Obstructing Nephrolithiasis in an 84-year-old Patient With a Diaphragmatic Herniated Ureter.
    Urology Volume: 124 Page(s): e1 - e3
    02/01/2019 Authors: Beland LE; Henry MA; Solomon T; Ogan K
  • New Preoperative Inflammatory Score Is an Independent and Significant Predictor of Overall Survival in Localized Clear Cell Renal Cell Carcinoma
    Volume: 227 Page(s): E244 - E244
    10/01/2018 Authors: Melnick KR; Khan AI; Patil D; Kim F; Patel AP; Bilen MA; Kucuk O; Filson CP; Ogan K; Master V
  • High Preoperative Neutrophil-to-Lymphocyte Ratio Predicts Overall Survival in Localized and Metastatic Clear Cell Renal Cell Carcinoma
    Volume: 227 Page(s): E243 - E243
    10/01/2018 Authors: Khan AI; Melnick KR; Patil D; Kim F; Laganosky DD; Bilen MA; Kucuk O; Filson CP; Ogan K; Master V
  • Serial Measurements of C-Reactive Protein: Albumin Ratio Can Stratify Risk and Survival in Patients with Clear Cell Renal Cell Carcinoma
    Volume: 227 Page(s): E245 - E245
    10/01/2018 Authors: Laganosky DD; Khan AI; Patil D; Lay AH; Pattaras JG; Bilen MA; Kucuk O; Ogan K; Master V
  • Editorial Comment.
    J Urol Volume: 199 Page(s): 926
    04/01/2018 Authors: Ogan K
  • RANDOMIZED TRIAL COMPARING THE SAFETY AND CLARITY OF WATER VERSUS SALINE IRRIGANT IN URETEROSCOPY
    Volume: 199 Page(s): E747 - E747
    04/01/2018 Authors: Pirani F; Makhani S; Kim F; Lay A; Cimmino C; Hartsell L; Spence A; Master V; Ogan K
  • Long-Term Renal Function Recovery following Radical Nephrectomy for Kidney Cancer: Results from a Multicenter Confirmatory Study EDITORIAL COMMENT
    JOURNAL OF UROLOGY Volume: 199 Page(s): 926 - 926
    04/01/2018 Authors: Ogan K
  • Single center validation of neutrophil-to-lymphocyte ratio in localized and metastatic clear cell renal cell carcinoma.
    Volume: 36
    02/20/2018 Authors: Melnick KR; Patil DH; Khan AI; Kim FY; Torlak M; Bilen MA; Kucuk O; Carthon BC; Filson CP; Ogan K
  • Evaluation of preoperative C-reactive protein: Albumin ratio in patients with clear cell renal cell carcinoma.
    Volume: 36
    02/20/2018 Authors: Patil DH; Williams S; Torlak M; Alemozaffar M; Lay A; Pattaras J; Kucuk O; Carthon BC; Bilen MA; Ogan K
  • Level of preoperative CRP as an independent predictor of survival in patients after nephrectomy for renal cell carcinoma: Long-term outcomes.
    Volume: 36
    02/20/2018 Authors: Saon M; Patil DH; Ding T; Kim FY; Torlak M; Ogan K; Master VA
  • Validation of a novel preoperative inflammatory score in localized, clear cell RCC.
    Volume: 36
    02/20/2018 Authors: Melnick KR; Patil DH; Khan AI; Kim FY; Bilen MA; Carthon BC; Kucuk O; Filson CP; Ogan K; Kissick HT
  • Cognitive Impairment and Overall Survival in Frail Surgical Patients.
    J Am Coll Surg Volume: 225 Page(s): 590 - 600.e1
    11/01/2017 Authors: Makhani SS; Kim FY; Liu Y; Ye Z; Li JL; Revenig LM; Vaughan CP; Johnson TM; Garca PS; Ogan K
  • Intravesical rAd-IFN/Syn3 for Patients With High-Grade, Bacillus Calmette-Guerin-Refractory or Relapsed Non-Muscle-Invasive Bladder Cancer: A Phase II Randomized Study.
    J Clin Oncol Volume: 35 Page(s): 3410 - 3416
    10/20/2017 Authors: Shore ND; Boorjian SA; Canter DJ; Ogan K; Karsh LI; Downs TM; Gomella LG; Kamat AM; Lotan Y; Svatek RS
  • Pelvic Lymphadenectomy in Intermediate to High-Risk Prostate Cancer (CaP) Patients: A Comparison of Robotic and Open Approaches
    Volume: 225 Page(s): E51 - E51
    10/01/2017 Authors: Pattaras JG; Laganosky D; Patil D; Ogan K; Michigan A
  • A Minimally Invasive Approach for Inguinal Lymphadenectomy in Melanoma and Genitourinary Malignancy: Long-Term Outcomes in an Attempted Randomized Control Trial.
    Ann Surg Oncol Volume: 24 Page(s): 3237 - 3244
    10/01/2017 Authors: Postlewait LM; Farley CR; Diller ML; Martin B; Hart Squires M; Russell MC; Rizzo M; Ogan K; Master V; Delman K
  • A novel preoperative inflammatory marker prognostic score in patients with localized and metastatic renal cell carcinoma.
    Asian J Urol Volume: 4 Page(s): 230 - 238
    10/01/2017 Authors: Sekar RR; Patil D; Baum Y; Pearl J; Bausum A; Bilen MA; Kucuk O; Harris WB; Carthon BC; Alemozaffar M
  • Frailty and cancer: Implications for oncology surgery, medical oncology, and radiation oncology.
    CA Cancer J Clin Volume: 67 Page(s): 362 - 377
    09/01/2017 Authors: Ethun CG; Bilen MA; Jani AB; Maithel SK; Ogan K; Master VA
  • Partial Nephrectomy is Associated with Higher Risk of Relapse Compared with Radical Nephrectomy for Clinical Stage T1 Renal Cell Carcinoma Pathologically Up Staged to T3a EDITORIAL COMMENTS
    JOURNAL OF UROLOGY Volume: 198 Page(s): 295 - 296
    08/01/2017 Authors: Ogan K
  • Patient Frailty and Discharge Disposition Following Radical Cystectomy.
    Clin Genitourin Cancer Volume: 15 Page(s): e615 - e621
    08/01/2017 Authors: Pearl JA; Patil D; Filson CP; Arya S; Alemozaffar M; Master VA; Ogan K
  • Editorial Comment.
    J Urol Volume: 198 Page(s): 295 - 296
    08/01/2017 Authors: Ogan K
  • Single institution experience on papillary renal cell carcinoma PD-1/13D-L1 expression, pathological analysis, and outcomes after nephrectomy.
    Volume: 35
    05/20/2017 Authors: Carthon BC; Tabba M; Harris W; Kucuk O; Master VA; Ogan K; Osunkoya A; Ellis C
  • Treatment of men with high-risk prostate cancer based on race, insurance coverage, and access to advanced technology.
    Urol Oncol Volume: 35 Page(s): 250 - 256
    05/01/2017 Authors: Gerhard RS; Patil D; Liu Y; Ogan K; Alemozaffar M; Jani AB; Kucuk ON; Master VA; Gillespie TW; Filson CP
  • Upper pole urologist-obtained percutaneous renal access for PCNL is safe and efficacious.
    Can J Urol Volume: 24 Page(s): 8754 - 8758
    04/01/2017 Authors: Patel AP; Bui D; Pattaras J; Ogan K
  • Increasing Tumor Burden in Radical Nephrectomy Specimens (RN) Corresponds to a Positive Delta in Estimated Glomerular Filtration Rate Over Time
    Volume: 30 Page(s): 411A - 411A
    02/01/2017 Authors: Wooten M; Hassan M; Rogers T; Farris AB; Ogan K; Ellis C
  • Increasing Tumor Burden in Radical Nephrectomy Specimens (RN) Corresponds to a Positive Delta in Estimated Glomerular Filtration Rate Over Time
    Volume: 97 Page(s): 411A - 411A
    02/01/2017 Authors: Wooten M; Hassan M; Rogers T; Farris AB; Ogan K; Ellis C
  • Ureteroscopy versus Shock Wave Lithotripsy: Factors Influencing Patient Treatment Preferences.
    Urol Pract Volume: 3 Page(s): 423 - 429
    11/01/2016 Authors: Gerhard RS; Shrewsberry A; Solomon T; Nickleach D; Liu Y; Pattaras J; Ogan K
  • Author Reply.
    Urology Volume: 96 Page(s): 105
    10/01/2016 Authors: Broggi MS; Patil D; Baum Y; Nieh PT; Alemozaffar M; Pattaras JG; Ogan K; Master VA
  • Onodera's Prognostic Nutritional Index as an Independent Prognostic Factor in Clear Cell Renal Cell Carcinoma.
    Urology Volume: 96 Page(s): 99 - 105
    10/01/2016 Authors: Broggi MS; Patil D; Baum Y; Nieh PT; Alemozaffar M; Pattaras JG; Ogan K; Master VA
  • Patient Frailty and Discharge Disposition after Radical Cystectomy
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS Volume: 223 Page(s): S161 - S162
    10/01/2016 Authors: Pearl J; Patil D; Arya S; Alemozaffar M; Master VA; Ogan K
  • Utility of Prostate Cancer Screening in Kidney Transplant Candidates.
    J Am Soc Nephrol Volume: 27 Page(s): 2157 - 2163
    07/01/2016 Authors: Vitiello GA; Sayed BA; Wardenburg M; Perez SD; Keith CG; Canter DJ; Ogan K; Pearson TC; Turgeon N
  • Frailty and one-year mortality in major intra-abdominal operations.
    J Surg Res Volume: 203 Page(s): 507 - 512.e1
    06/15/2016 Authors: Li JL; Henderson MA; Revenig LM; Sweeney JF; Kooby DA; Maithel SK; Master VA; Ogan K
  • Safety and Efficacy of Ureteral Stent Placement at the Bedside Using Local Anesthesia.
    Volume: 195 Page(s): 1886 - 1890
    06/01/2016 Authors: Nourparvar P; Leung A; Shrewsberry AB; Weiss AD; Patil D; Atallah H; Ogan K; Carney KJ; Master VA
  • Initial comparison of Tc-99m-NTA and Tc-99m-MAG3 in patients with suspected obstruction
    Volume: 57
    05/01/2016 Authors: Taylor A; Lipowska M; Folks R; Halkar R; John PG; Ogan K
  • EXTERNAL VALIDATION OF PREOPERATIVE AST/ALT (DE-RITIS) RATIO AS A PROGNOSTIC INDICATOR IN LOCALIZED AND METASTATIC RENAL CELL CARCINOMA
    Volume: 195 Page(s): E967 - E967
    04/01/2016 Authors: Patil D; Sekar R; Pearl J; Baum Y; Wehrmeyer K; Torlak M; Alemozaffar M; Filson C; Ogan K; Master V
  • THE RELATIONSHIP BETWEEN PREOPERATIVE C - REACTIVE PROTEIN AND FUHRMAN NUCLEAR GRADE IN STAGE T1 RENAL CELL CARCINOMA
    Volume: 195 Page(s): E1033 - E1033
    04/01/2016 Authors: Sekar R; Patil D; Pearl J; Baum Y; Spetka S; Alemozaffar M; Filson C; Pattaras J; Ogan K; Master V
  • BLOOD SAMPLING FOR LIQUID BIOPSY OF RENAL CELL CARCINOMA OVERCOMES SAMPLING ERROR ASSOCIATED WITH BIOPSY FOR MOLECULAR GENOTYPING
    Volume: 195 Page(s): E915 - E915
    04/01/2016 Authors: Keith C; Lian F; Arnold R; Rossi M; Osunkoya A; Goecks J; Gaspar J; Ogan K; Pattaras J; Master V
  • FRAIL PATIENTS ARE LESS LIKELY TO BE DISCHARGED TO HOME AFTER CYSTECTOMY
    Volume: 195 Page(s): E71 - E72
    04/01/2016 Authors: Pearl J; Patil D; Arya S; Alemozaffar M; Master V; Ogan K
  • DELAYED TREATMENT OF HIGH-RISK PROSTATE CANCER PATIENTS: IMPACT OF SOCIOECONOMIC BARRIERS AND USE OF ADVANCED TECHNOLOGIES
    Volume: 195 Page(s): E499 - E499
    04/01/2016 Authors: Gerhard RS; Patil D; Liu Y; Ogan K; Alemozaffar M; Jani A; Kucuk O; Master V; Gillespie T; Filson C
  • Major histocompatibility complex I upregulation in clear cell renal cell carcinoma is associated with increased survival.
    Asian J Urol Volume: 3 Page(s): 75 - 81
    04/01/2016 Authors: Sekar RR; De La Calle CM; Patil D; Holzman SA; Baum Y; Sheikh U; Huang JH; Osunkoya AO; Pollack BP; Kissick HT
  • External validation of preoperative AST/ALT (De-Ritis) ratio as a prognostic indicator in localized and metastatic renal cell carcinoma.
    Volume: 34
    01/10/2016 Authors: Patil DH; Sekar RR; Pearl J; Baum Y; Alemozaffar M; Filson CP; Ogan K; Master VA
  • A novel preoperative inflammatory marker prognostic score in patients with clear cell and non-clear cell renal cell carcinoma.
    Volume: 34
    01/10/2016 Authors: Sekar RR; Patil D; Pearl J; Baum Y; Kucuk O; Harris WB; Carthon B; Alemozaffar M; Filson CP; Ogan K
  • The relationship between preoperative c-reactive protein and Fuhrman nuclear grade in stage T1 renal cell carcinoma.
    Volume: 34
    01/10/2016 Authors: Sekar RR; Patil D; Pearl J; Baum Y; Alemozaffar M; Filson CP; Ogan K; Master VA
  • Elevated preoperative neutrophil-to-lymphocyte ratio may be associated with decreased overall survival in patients with metastatic clear cell renal cell carcinoma undergoing cytoreductive nephrectomy.
    Asian J Urol Volume: 3 Page(s): 20 - 25
    01/01/2016 Authors: Baum YS; Patil D; Huang JH; Spetka S; Torlak M; Nieh PT; Alemozaffar M; Ogan K; Master VA
  • C-reactive protein in urologic cancers.
    Mol Aspects Med Volume: 45 Page(s): 28 - 36
    11/01/2015 Authors: Huang J; Baum Y; Alemozaffar M; Ogan K; Harris W; Kucuk O; Master VA
  • A new inflammatory-based marker prognostic score in a large cohort of patients with localized clear cell renal cell carcinoma
    Volume: 221 Page(s): E147 - E147
    10/01/2015 Authors: Baum YS; Patil D; Huang JH; Bausum A; Ogan K; Master VA
  • Impact of remote monitoring and supervision on resident training using new ACGME milestone criteria.
    Can J Urol Volume: 22 Page(s): 7959 - 7964
    10/01/2015 Authors: Safir IJ; Shrewsberry AB; Issa IM; Ogan K; Ritenour CWM; Sullivan J; Issa MM
  • Kinetic risk assessment with biomarkers of systemic inflammation in patients with metastatic renal cell carcinoma
    Volume: 75
    08/01/2015 Authors: Harris WB; Kucuk O; Carthon B; Liu Y; Pattaras J; Ogan K; Master V
  • Sarcomatoid urothelial carcinoma of the bladder: a contemporary clinicopathologic analysis of 37 cases.
    Can J Urol Volume: 22 Page(s): 7783 - 7787
    06/01/2015 Authors: Fatima N; Canter DJ; Carthon BC; Kucuk O; Master VA; Nieh PT; Ogan K; Osunkoya AO
  • Report of a Simplified Frailty Score Predictive of Short-Term Postoperative Morbidity and Mortality.
    J Am Coll Surg Volume: 220 Page(s): 904 - 11.e1
    05/01/2015 Authors: Revenig LM; Canter DJ; Kim S; Liu Y; Sweeney JF; Sarmiento JM; Kooby DA; Maithel SK; Hill LL; Master VA
  • WAG THE DOG?: PSA SCREENING IN KIDNEY TRANSPLANT CANDIDATES
    Volume: 193 Page(s): E1011 - E1011
    04/01/2015 Authors: Canter D; Vitiello G; Sayed B; Ogan K; Turgeon N
  • PRE-OPERATIVE MODIFIED GLASGOW PROGNOSTIC SCORE AS AN INDEPENDENT PROGNOSIS FACTOR IN A LARGE US POPULATION
    Volume: 193 Page(s): E529 - E529
    04/01/2015 Authors: Baum Y; De la Calle C; Patil D; Schwartz R; Huang J; Ogan K; Alemozaffar M; Pattaras J; Nieh P; Master V
  • COMMONLY-USED COST-EFFECTIVE PRE-OPERATIVE INFLAMMATORY MARKERS PROVIDE PROGNOSTIC INFORMATION IN PATIENTS WITH LOCALIZED CLEAR CELL RENAL CELL CARCINOMA
    Volume: 193 Page(s): E424 - E424
    04/01/2015 Authors: Baum Y; De la Calle C; Patil D; Bausum A; Huang J; Alemozaffar M; Pattaras J; Nieh P; Ogan K; Master V
  • Nomograms incorporating serum C-reactive protein effectively predict mortality before and after surgical treatment of renal cell carcinoma.
    Int J Urol Volume: 22 Page(s): 264 - 270
    03/01/2015 Authors: Hsiao W; Herrel LA; Yu C; Kattan MW; Canter DJ; Carthon BC; Ogan K; Master VA
  • Evaluation of major histocompatibility complex class I expression in clear cell renal cell carcinoma as a prognostic tool
    Volume: 33
    03/01/2015 Authors: de la Calle CM; Holzman SA; Sheikh U; Huang JH; Kissick HT; Osunkoya AO; Pollack BP; Patil D; Ogan K; Master VA
  • Preoperative quantification of perceptions of surgical frailty.
    J Surg Res Volume: 193 Page(s): 583 - 589
    02/01/2015 Authors: Revenig LM; Canter DJ; Henderson MA; Ogan K; Kooby DA; Maithel SK; Liu Y; Kim S; Master VA
  • High Expression of Major Histocompatibility Complex Class I in Clear Cell Renal Cell Carcinoma Is Associated with Improved Prognosis.
    Urol Int Volume: 95 Page(s): 72 - 78
    01/01/2015 Authors: Holzman SA; de la Calle CM; Kissick HT; Osunkoya AO; Pollack BP; Patil D; Ogan K; Master VA
  • von Hippel-Lindau exonic methylation analysis using MALDI-TOF mass spectrometry.
    J Urol Volume: 192 Page(s): 1528 - 1533
    11/01/2014 Authors: Lian F; Sreedharan S; Arnold RS; Master VA; Ogan K; Pattaras JG; Roberts DL; Petros JA
  • Stubborn as a Stone: A Case of Hereditary Pancreatitis Causing Difficult-to-Manage Pancreatic Stone and Review of Endoscopic and Surgical Management Options
    Volume: 109 Page(s): S314 - S314
    10/01/2014 Authors: Wang XJ; Sarmiento J; Ogan K; Bedolla G; Woods K
  • Eye of the beholder?: A prospective study examining the correlation between patients' and surgeons' subjective assessment of surgical frailty
    Volume: 219 Page(s): E18 - E18
    10/01/2014 Authors: Canter DJ; Revenig L; Ogan K; Kooby DA; Maithel S; Sweeney JF; Sarmiento JM; Liu Y; Kim S; Master VA
  • Evaluation of the Safety and Quality of Videoscopic Inguinal Lymphadenectomy: Mitigation of Patient Comorbidities by a Minimally Invasive Technique
    Volume: 219 Page(s): S124 - S124
    09/01/2014 Authors: Squires MH; Master VA; Kooby DA; Russell MC; Rizzo M; Ogan K; Martin BM; Longwell AB; Carlson GW; Delman KA
  • The Effect of PSA Screening On Kidney Transplant Evaluation and Transplantation.
    Volume: 98 Page(s): 840 - 840
    07/15/2014 Authors: Vitiello G; Wardenburg M; Perez S; Ogan K; Turgeon N
  • The Effect of PSA Screening On Kidney Transplant Evaluation and Transplantation.
    Volume: 14 Page(s): 840 - 840
    06/01/2014 Authors: Vitiello G; Wardenburg M; Perez S; Ogan K; Turgeon N
  • VON HIPPEL-LINDAU EXONIC METHYLATION ANALYSIS USING MALDI-TOF MASS SPECTROMETRY
    Volume: 191 Page(s): E248 - E249
    04/01/2014 Authors: Lian F; Sreedharan S; Arnold RS; Master VA; Ogan K; Pattaras JG; Roberts DL; Ressler K; Petros JA
  • MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I EXPRESSION IN CLEAR CELL RENAL CELL CARCINOMA: CORRELATION WITH CLINICAL OUTCOME
    Volume: 191 Page(s): E379 - E380
    04/01/2014 Authors: Holzman S; Osunkoya A; Pollack B; Ogan K; Master V
  • A prospective study examining the association between preoperative frailty and postoperative complications in patients undergoing minimally invasive surgery.
    J Endourol Volume: 28 Page(s): 476 - 480
    04/01/2014 Authors: Revenig LM; Canter DJ; Master VA; Maithel SK; Kooby DA; Pattaras JG; Tai C; Ogan K
  • Renal cell carcinoma in patients with end-stage renal disease has favorable overall prognosis.
    Clin Transplant Volume: 28 Page(s): 211 - 216
    02/01/2014 Authors: Shrewsberry AB; Osunkoya AO; Jiang K; Westby R; Canter D; Pattaras J; Turgeon N; Master VA; Ogan K
  • Aquaporin-1 protein levels elevated in fresh urine of renal cell carcinoma patients: potential use for screening and classification of incidental renal lesions.
    Dis Markers Volume: 2014 Page(s): 135649
    01/01/2014 Authors: Sreedharan S; Petros JA; Master VA; Ogan K; Pattaras JG; Roberts DL; Lian F; Arnold RS
  • External validation of the modified Glasgow prognostic score for renal cancer.
    Indian J Urol Volume: 30 Page(s): 33 - 37
    01/01/2014 Authors: Tai CG; Johnson TV; Abbasi A; Herrell L; Harris WB; Kucuk O; Canter DJ; Ogan K; Pattaras JG; Nieh PT
  • Too frail for surgery? Initial results of a large multidisciplinary prospective study examining preoperative variables predictive of poor surgical outcomes.
    J Am Coll Surg Volume: 217 Page(s): 665 - 670.e1
    10/01/2013 Authors: Revenig LM; Canter DJ; Taylor MD; Tai C; Sweeney JF; Sarmiento JM; Kooby DA; Maithel SK; Master VA; Ogan K
  • Initial experience assessing pre-operative frailty with patients undergoing radical cystectomy for urothelial cancer
    Volume: 217 Page(s): S146 - S147
    09/01/2013 Authors: Revenig LM; Tai CG; Taylor MD; Master VA; Ogan K; Canter DJ
  • Reply by the authors.
    Urology Volume: 81 Page(s): 1117
    05/01/2013 Authors: Herrel L; Pattaras J; Solomon T; Ogan K
  • Use of full-length metallic stents in malignant ureteral obstruction.
    J Endourol Volume: 27 Page(s): 640 - 645
    05/01/2013 Authors: Abbasi A; Wyre HW; Ogan K
  • Re: Herrel et al.: Urinary Stone Risk and Cola Consumption. (Urology 2012;80:990-994) Reply
    UROLOGY Volume: 81 Page(s): 1117 - 1117
    05/01/2013 Authors: Herrel L; Pattaras J; Solomon T; Ogan K
  • INITIAL EXPERIENCE ASSESSING PRE-OPERATIVE FRAILTY WITH PATIENTS UNDERGOING RADICAL CYSTECTOMY FOR UROTHELIAL CANCER
    Volume: 189 Page(s): E212 - E212
    04/01/2013 Authors: Ogan K; Taylor MD; Tai CG; Herrel LA; Cross B; Master VA; Carthon BC; Canter D
  • NOMOGRAMS INCORPORATING SERUM C-REACTIVE PROTEIN (CRP) LEVELS EFFECTIVELY PREDICT MORTALITY AFTER NEPHRECTOMY.
    Volume: 189 Page(s): E306 - E307
    04/01/2013 Authors: Hsiao W; Herrel L; Yu C; Kattan M; Ogan K; Canter D; Pattaras J; Nieh P; Harris W; Carthon B
  • RENAL CELL CARCINOMA IN PATIENTS WITH END-STAGE RENAL DISEASE HAS FAVORABLE OVERALL PROGNOSIS
    Volume: 189 Page(s): E303 - E303
    04/01/2013 Authors: Shrewsberry A; Osunkoya A; Jiang K; Westby R; Canter D; Pattaras J; Turgeon N; Master V; Ogan K
  • Computed tomography based renal parenchyma volume measurements prior to renal tumor surgery are predictive of postoperative renal function.
    Can J Urol Volume: 20 Page(s): 6714 - 6720
    04/01/2013 Authors: Kunzel B; Small W; Goodman M; Pattaras J; Master V; Ogan K
  • DEVELOPMENT OF A TEST FOR RCC BY DETECTION OF VHL MUTATIONS IN TISSUE AND FLUIDS OF PATIENTS WITH RENAL CELL CARCINOMA
    Volume: 189 Page(s): E249 - E250
    04/01/2013 Authors: Sreedharan S; Arnold RS; Kerley K; Mercer KB; Ressler K; Master VA; Ogan K; Roberts DL; Pattaras JG; Petros JA
  • Preoperative C-reactive protein combined with SSIGN score as an independent predictor of cancer-specific survival in patients with clear cell renal cell carcinoma.
    Volume: 31 Page(s): 451
    02/20/2013 Authors: Tai CG-L; Westby R; Ogan K; Canter D; Pattaras J; Nieh P; Master VA
  • Postoperative modified Glasgow prognostic score as an independent predictor of overall survival in clinically localized clear cell renal cell carcinoma.
    Volume: 31 Page(s): 456
    02/20/2013 Authors: Tai CG-L; Westby R; Ogan K; Canter D; Pattaras J; Nieh P; Master VA
  • Urinary stone risk and cola consumption.
    Urology Volume: 80 Page(s): 990 - 994
    11/01/2012 Authors: Herrel L; Pattaras J; Solomon T; Ogan K
  • Minimally invasive inguinal lymphadenectomy via endoscopic groin dissection: comprehensive assessment of immediate and long-term complications.
    J Urol Volume: 188 Page(s): 1176 - 1180
    10/01/2012 Authors: Master VA; Jafri SMA; Moses KA; Ogan K; Kooby DA; Delman KA
  • COMPUTED TOMOGRAPHY BASED RENAL PARENCHYMAL VOLUME MEASUREMENTS PRIOR TO RENAL TUMOR SURGERY IS PREDICTIVE OF POSTOPERATIVE RENAL FUNCTION
    JOURNAL OF ENDOUROLOGY Volume: 26 Page(s): A241 - A242
    09/01/2012 Authors: Ogan K; Kunzel B; Small W; Goodman M; Faurot M; Pattaras J; Master V
  • PERCUTANEOUS ENDOSCOPIC LASER LITHOTRIPSY IN ORTHOTOPIC LIVER TRANSPLANT PATIENTS FOR COMPLEX BILIARY CALCULI
    JOURNAL OF ENDOUROLOGY Volume: 26 Page(s): A180 - A180
    09/01/2012 Authors: Angell JE; Winship B; Healy K; Martin L; Ogan K
  • Robotic management of benign mid and distal ureteral strictures and comparison with laparoscopic approaches at a single institution.
    Urology Volume: 80 Page(s): 596 - 601
    09/01/2012 Authors: Baldie K; Angell J; Ogan K; Hood N; Pattaras JG
  • Health related quality of life for stone formers.
    J Urol Volume: 188 Page(s): 436 - 440
    08/01/2012 Authors: Bryant M; Angell J; Tu H; Goodman M; Pattaras J; Ogan K
  • Functional, oncologic, and technical outcomes after endoscopic groin dissection for penile carcinoma.
    Can J Urol Volume: 19 Page(s): 6395 - 6400
    08/01/2012 Authors: Canter DJ; Dobbs RW; Jafri SMA; Herrel LA; Ogan K; Delman KA; Master VA
  • Prospective pilot study of smoking cessation in patients undergoing urologic surgery.
    Urology Volume: 80 Page(s): 104 - 109
    07/01/2012 Authors: Kunzel B; Cabalza J; Faurot M; Solomon T; Nieh P; Pattaras J; Master VA; Ogan K
  • Bilateral endoscopic inguinofemoral lymphadenectomy using simultaneous carbon dioxide insufflation: an initial report of a novel approach.
    Can J Urol Volume: 19 Page(s): 6306 - 6309
    06/01/2012 Authors: Herrel LA; Butterworth RM; Jafri SM; Ying C; Delman KA; Kooby DA; Ogan KE; Canter DJ; Master VA
  • Efficacy and tolerability of biweekly gemcitabine plus cisplatin (GEMCIS) or gemcitabine plus paclitaxel (GEMPAC) as neoadjuvant chemotherapy in patients with muscle invasive urothelial carcinoma of the bladder
    Volume: 30
    05/20/2012 Authors: Karaoglu A; Nieh P; Canter D; Master VA; Carthon B; Harris W; Shelton J; Rossi PJ; Jani AB; Khan MK
  • MINIMALLY INVASIVE INGUINAL LYMPHADENECTOMY VIA ENDOSCOPIC GROIN DISSECTION: COMPREHENSIVE ASSESSMENT OF IMMEDIATE AND LONG-TERM COMPLICATIONS
    Volume: 187 Page(s): E376 - E376
    04/01/2012 Authors: Master VA; Jafri SMA; Herrel L; Ogan K; Kooby DA; Delman KA
  • Initial North American experience with the use of the Olympus Button Electrode for vaporization of bladder tumors.
    Can J Urol Volume: 19 Page(s): 6211 - 6216
    04/01/2012 Authors: Canter DJ; Ogan K; Master VA
  • EXTERNAL VALIDATION OF THE MODIFIED GLASGOW PROGNOSTIC SCORE (MGPS) FOR RENAL CANCER
    Volume: 187 Page(s): E680 - E680
    04/01/2012 Authors: Cross B; Johnson T; Kucuk O; Canter D; Pattaras J; Ogan K; Nieh P; Harris W; Master V
  • Association of depression and urolithiasis.
    Urology Volume: 79 Page(s): 518 - 525
    03/01/2012 Authors: Angell J; Bryant M; Tu H; Goodman M; Pattaras J; Ogan K
  • External validation of the Glasgow prognostic score (mGPS) for renal cancer.
    J Clin Oncol Volume: 30 Page(s): 378
    02/10/2012 Authors: Master VA; Johnson TV; Kucuk O; Canter D; Pattaras J; Ogan K; Cross B; Nieh PT; Harris W
  • External validation of the Glasgow prognostic score (mGPS) for renal cancer.
    J Clin Oncol Volume: 30 Page(s): 378
    02/10/2012 Authors: Master VA; Johnson TV; Kucuk O; Canter D; Pattaras J; Ogan K; Cross B; Nieh PT; Harris W
  • External validation of the Glasgow prognostic score (mGPS) for renal cancer.
    JOURNAL OF CLINICAL ONCOLOGY Volume: 30
    02/10/2012 Authors: Master VA; Johnson TV; Kucuk O; Canter D; Pattaras J; Ogan K; Cross B; Nieh PT; Harris W
  • Preoperative Erythrocyte Sedimentation Rate Independently Predicts Overall Survival in Localized Renal Cell Carcinoma following Radical Nephrectomy.
    Int J Surg Oncol Volume: 2012 Page(s): 524981
    01/01/2012 Authors: Cross BW; Johnson TV; Derosa AB; Ogan K; Pattaras JG; Nieh PT; Kucuk O; Harris WB; Master VA
  • Intratumor C-reactive protein as a biomarker of prognosis in localized renal cell carcinoma.
    J Urol Volume: 186 Page(s): 1213 - 1217
    10/01/2011 Authors: Johnson TV; Ali S; Abbasi A; Kucuk O; Harris WB; Ogan K; Pattaras J; Nieh PT; Marshall FF; Osunkoya AO
  • Intra-tumor Doppler flow patterns do not predict malignancy of renal masses in a United States population.
    Can J Urol Volume: 18 Page(s): 5831 - 5835
    08/01/2011 Authors: Hsiao W; Shrewsberry AB; Moses KA; Malek-Jones M; Baumgarten D; Master VA; Ogan K
  • Simple perioperative algorithm for serum C-reactive protein: A potent, independent, adverse prognostic factor for renal cell carcinoma
    CANCER RESEARCH Volume: 71
    04/15/2011 Authors: Harris WB; Lingerfelt BM; Chen Z; Kucuk O; Osunkoya AO; Pattaras JG; Ogan K; Nieh PT; Petros JA; Young AN
  • INTRATUMORAL C-REACTIVE PROTEIN AS A BIOMARKER OF PROGNOSIS IN LOCALIZED RENAL CELL CARCINOMA
    Volume: 185 Page(s): E667 - E668
    04/01/2011 Authors: Johnson T; Master V; Abbasi A; Kucuk O; Young A; Ogan K; Pattaras J; Nieh P; Marshall F; Osunkoya A
  • PROSPECTIVE STUDY OF SMOKING CESSATION IN PATIENTS UNDERGOING UROLOGIC SURGERY
    Volume: 185 Page(s): E23 - E23
    04/01/2011 Authors: Kunzel B; Cabalza J; Faurot M; Solomon T; Nieh P; Pattaras J; Master V; Ogan K
  • Initial experience with videoscopic inguinal lymphadenectomy.
    Ann Surg Oncol Volume: 18 Page(s): 977 - 982
    04/01/2011 Authors: Delman KA; Kooby DA; Rizzo M; Ogan K; Master V
  • Increased Expression of Intratumoral C-Reactive Protein Predicts Mortality in Patients with Localized Clear Cell Renal Cell Carcinoma.
    Volume: 24 Page(s): 176A - 176A
    02/01/2011 Authors: Ali S; Master VA; Abbasi A; Kucuk O; Young AN; Ogan K; Pattaras JG; Nieh PT; Marshall FF; Osunkoya AO
  • Increased Expression of Intratumoral C-Reactive Protein Predicts Mortality in Patients with Localized Clear Cell Renal Cell Carcinoma
    Volume: 91 Page(s): 176A - 176A
    02/01/2011 Authors: Ali S; Master VA; Abbasi A; Kucuk O; Young AN; Ogan K; Pattaras JG; Nieh PT; Marshall FF; Osunkoya AO
  • Same session bilateral ureteroscopy is safe and efficacious.
    J Urol Volume: 185 Page(s): 170 - 174
    01/01/2011 Authors: Watson JM; Chang C; Pattaras JG; Ogan K
  • Estimated volume growth characteristics of renal tumors undergoing active surveillance.
    Can J Urol Volume: 17 Page(s): 5459 - 5464
    12/01/2010 Authors: Hwang CK; Ogan K; Pattaras J; Master VA
  • Acute abdominal pain: is there a potential role for MRI in the setting of the emergency department in a patient with renal calculi?
    J Magn Reson Imaging Volume: 32 Page(s): 1012 - 1023
    11/01/2010 Authors: Kalb B; Sharma P; Salman K; Ogan K; Pattaras JG; Martin DR
  • A NEW CONCERN FOR OUR STONE PATIENTS: DEPRESSION
    JOURNAL OF ENDOUROLOGY Volume: 24 Page(s): A200 - A201
    09/01/2010 Authors: Angell JE; Bryant M; Goodman M; Pattaras J; Ogan K
  • A RANDOMIZED, DOUBLE-BLIND STUDY COMPARING THE USE OF WATER VERSUS SALINE IRRIGATION DURING URETEROSCOPY
    JOURNAL OF ENDOUROLOGY Volume: 24 Page(s): A221 - A221
    09/01/2010 Authors: Wyre H; Lee J; Ogan K
  • Postoperative better than preoperative C-reactive protein at predicting outcome after potentially curative nephrectomy for renal cell carcinoma.
    Urology Volume: 76 Page(s): 766.e1 - 766.e5
    09/01/2010 Authors: Johnson TV; Abbasi A; Owen-Smith A; Young AN; Kucuk O; Harris WB; Osunkoya AO; Ogan K; Pattaras J; Nieh PT
  • The impact of income and education on dietary habits in stone formers.
    Urology Volume: 76 Page(s): 307 - 313
    08/01/2010 Authors: Saint-Elie DT; Patel PV; Healy KA; Solomon T; Pattaras JG; Qian J; Master VA; Ogan K
  • Serum testosterone may be associated with calcium oxalate urolithogenesis.
    J Endourol Volume: 24 Page(s): 1183 - 1187
    07/01/2010 Authors: Watson JM; Shrewsberry AB; Taghechian S; Goodman M; Pattaras JG; Ritenour CWM; Ogan K
  • POSTOPERATIVE BETTER THAN PREOPERATIVE C-REACTIVE PROTEIN AT PREDICTING OUTCOME FOLLOWING POTENTIALLY CURATIVE NEPHRECTOMY FOR RENAL CELL CARCINOMA
    Volume: 183 Page(s): E198 - E198
    04/01/2010 Authors: Master V; Johnson T; Abbasi A; Owen-Smith A; Young A; Kucuk O; Harris W; Osunkoye A; Ogan K; Pattaras J
  • Feasibility of a novel approach to inguinal lymphadenectomy: minimally invasive groin dissection for melanoma.
    Ann Surg Oncol Volume: 17 Page(s): 731 - 737
    03/01/2010 Authors: Delman KA; Kooby DA; Ogan K; Hsiao W; Master V
  • Growing Experience with Videoscopic Inguinal Lymphadenectomy (VIL): Moving Towards Better Outcomes
    Volume: 17 Page(s): S15 - S15
    02/01/2010 Authors: Delman KA; Kooby DA; Rizzo M; Ogan K; Maithel SK; Master V
  • Absolute preoperative C-reactive protein predicts metastasis and mortality in the first year following potentially curative nephrectomy for clear cell renal cell carcinoma.
    J Urol Volume: 183 Page(s): 480 - 485
    02/01/2010 Authors: Johnson TV; Abbasi A; Owen-Smith A; Young A; Ogan K; Pattaras J; Nieh P; Marshall FF; Master VA
  • Leg endoscopic groin lymphadenectomy (LEG procedure): step-by-step approach to a straightforward technique.
    Eur Urol Volume: 56 Page(s): 821 - 828
    11/01/2009 Authors: Master V; Ogan K; Kooby D; Hsiao W; Delman K
  • LEG ENDOSCOPIC GROIN LYMPHADENECTOMY FOR GENITOURINARY CANCER (LEG PROCEDURE)
    JOURNAL OF ENDOUROLOGY Volume: 23 Page(s): A53 - A53
    10/01/2009 Authors: Master V; Ogan K; Kooby D; Hsiao W; Delman K
  • Controversial case in endourology. A 27-year-old man suffered a blast injury while serving in Iraq. A right perinephric hematoma and shrapnel near the hilum of the right kidney were noted on CT.
    J Endourol Volume: 23 Page(s): 1223 - 1225
    08/01/2009 Authors: Wong C; Ogan K; Pareek G
  • Effects of obesity and weight loss in patients with nononcological urological disease.
    J Urol Volume: 181 Page(s): 2424 - 2429
    06/01/2009 Authors: Natarajan V; Master V; Ogan K
  • IMPACT OF WEIGHT LOSS ON SEXUAL FUNCTION IN OBESE WOMEN
    Volume: 181 Page(s): 564 - 565
    04/01/2009 Authors: Saint-Elie DT; Healy KA; Williams J; Lin E; Davis SS; Ritenour CW; Pattaras JG; Master VA; Ogan K
  • ENDOSCOPIC MODIFIED INGUINAL LYMPHADENECTOMY: LEG ENDOSCOPIC GROIN (LEG) PROCEDURE
    Volume: 181 Page(s): 605 - 606
    04/01/2009 Authors: Hsiao W; Herrel L; Delman KA; Ogan K; Master VA
  • Percutaneous endoscopic holmium laser lithotripsy for management of complicated biliary calculi.
    JSLS Volume: 13 Page(s): 184 - 189
    01/01/2009 Authors: Healy K; Chamsuddin A; Spivey J; Martin L; Nieh P; Ogan K
  • Laparoscopic donor nephrectomy: Multiple arteries are not a predictor of recipient outcomes.
    Volume: 8 Page(s): 457 - 457
    05/01/2008 Authors: Bearden CM; Tso PL; Turgeon NA; Ogan K; Pearson TC; Kirk AD; Larsen CP; Newell KA
  • Prospective randomized trial comparing shock wave lithotripsy and ureteroscopy for lower pole caliceal calculi 1 cm or less.
    J Urol Volume: 179 Page(s): S69 - S73
    05/01/2008 Authors: Pearle MS; Lingeman JE; Leveillee R; Kuo R; Preminger GM; Nadler RB; Macaluso J; Monga M; Kumar U; Dushinski J
  • Endourological management of urolithiasis in hepatically compromised patients.
    J Urol Volume: 179 Page(s): 976 - 980
    03/01/2008 Authors: Pattaras JG; Ogan K; Martinez E; Nieh P
  • Laparoscopic ureteral reimplant for distal ureteral strictures.
    JSLS Volume: 12 Page(s): 13 - 17
    01/01/2008 Authors: Ogan K; Abbott JT; Wilmot C; Pattaras JG
  • The Second Joint Meeting of American Urological Association (AUA)/Japanese Urological Association (JUA) International Program on the 102nd Annual Meeting of American Urological Association at Anaheim 2007.
    Int J Urol Volume: 14 Page(s): 1116 - 1123
    12/01/2007 Authors: Ogan K; Kawai K; Gill IS; Naito S; Isaacs WB; Suzuki K; Kibel AS; Kakehi Y; Yoshimura N; Yokoyama O
  • Renal tumor ablation: Past and present
    INTERNATIONAL JOURNAL OF UROLOGY Volume: 14 Page(s): 1117 - 1117
    12/01/2007 Authors: Ogan K
  • Occult spinal dysraphism and urolithiasis: are patients at higher risk of stone disease?
    J Endourol Volume: 21 Page(s): 1293 - 1296
    11/01/2007 Authors: Healy KA; Baumgarten DA; Lendvay TS; Fountain AJ; Galloway NTM; Ogan K
  • Endoscopic holmium laser lithotripsy for the management of complicated biliary calculi
    JOURNAL OF ENDOUROLOGY Volume: 21 Page(s): A162 - A163
    10/01/2007 Authors: Ogan K; Healy K; Chamsuddin A
  • Clinical experience of the first digital flexible ureteroscope
    JOURNAL OF ENDOUROLOGY Volume: 21 Page(s): A286 - A286
    10/01/2007 Authors: Pattaras J; Ogan K
  • Not so "Simple" laparoscopic nephrectomy: Outcomes and complications of a seven year experience
    JOURNAL OF ENDOUROLOGY Volume: 21 Page(s): A272 - A272
    10/01/2007 Authors: Pattaras J; Hsiao W; Ogan K
  • Laparoscopic ureteral reimplant for iatrogenic distal ureteral injury
    JOURNAL OF ENDOUROLOGY Volume: 21 Page(s): A130 - A130
    10/01/2007 Authors: Ogan K; Abbott J; Wilmot C; Pattaras J
  • Intermediate-term results of renal tumor ablation: Radioitrequency ablation versus cryotherapy
    JOURNAL OF ENDOUROLOGY Volume: 21 Page(s): A195 - A195
    10/01/2007 Authors: Ogan K; Healy K; Torres W; Small W; Bowen M; Pattaras J
  • Laparoscopic renal tumor cryoablation thermal based approach: Intermediate results
    JOURNAL OF ENDOUROLOGY Volume: 21 Page(s): A194 - A194
    10/01/2007 Authors: Pattaras J; Kozinn S; Tillett J; Nieh P; Ogan K
  • The techniques of trans-mesenteric laparoscopic dismembered pyeloplasty
    JOURNAL OF ENDOUROLOGY Volume: 21 Page(s): A177 - A177
    10/01/2007 Authors: Pattaras J; Ogan K
  • Pathophysiology and management of infectious staghorn calculi.
    Urol Clin North Am Volume: 34 Page(s): 363 - 374
    08/01/2007 Authors: Healy KA; Ogan K
  • Primary carcinoid tumor in an ileal conduit.
    Urology Volume: 68 Page(s): 672.e9 - 672.10
    09/01/2006 Authors: Klink J; Rutland H; Harik L; Ogan K
  • Comparison of renal tumor ablation at one institution: Radiofrequency ablation versus cryotherapy
    JOURNAL OF ENDOUROLOGY Volume: 20 Page(s): A41 - A41
    08/01/2006 Authors: Healy KA; Torres WE; Small WC; Bowen M; Pattaras JG; Ogan K
  • Effect of cola on urinary stone risk factors
    JOURNAL OF ENDOUROLOGY Volume: 20 Page(s): A146 - A146
    08/01/2006 Authors: Abbott JT; Goodman M; Pattaras JG; Ogan K
  • Laparoscopic assisted cryoablation of renal tumors: Temperature based model
    JOURNAL OF ENDOUROLOGY Volume: 20 Page(s): A174 - A174
    08/01/2006 Authors: Tillett J; Ogan K; Nieh P; Pattaras JG
  • Laparoscopic reconstruction of proximal ureteral strictures greater than 1.5 cm
    JOURNAL OF ENDOUROLOGY Volume: 20 Page(s): A48 - A48
    08/01/2006 Authors: Tillett J; Ogan K; Pattaras JG
  • Cytoreductive nephrectomy in metastatic renal cell carcinoma.
    Expert Rev Anticancer Ther Volume: 6 Page(s): 1295 - 1304
    08/01/2006 Authors: Healy KA; Marshall FF; Ogan K
  • Radiologic outcomes of renal tumor cryoablation
    JOURNAL OF ENDOUROLOGY Volume: 20 Page(s): A178 - A178
    08/01/2006 Authors: Tillett J; Ogan K; Pattaras JG
  • Cost analysis for four techniques of renal tumor ablation: Laparoscopic and percutaneous radiofrequency ablation and cryoablation.
    JOURNAL OF ENDOUROLOGY Volume: 20 Page(s): A7 - A7
    08/01/2006 Authors: Park S; Zeltser I; Dusseault B; Lotan Y; Pattaras JG; Ogan K
  • Salvage prostatectomy for prostate cancer (CaP): Data from the Surveillance Epidemiology and End Results (SEER) database.
    J Clin Oncol Volume: 24 Page(s): 4622
    06/20/2006 Authors: Johnstone PA; Goodman M; Ward K; Assikis V; Ogan K
  • Salvage prostatectomy for prostate cancer (CaP): Data from the Surveillance Epidemiology and End Results (SEER) database.
    Volume: 24 Page(s): 247S - 247S
    06/20/2006 Authors: Johnstone PA; Goodman M; Ward K; Assikis V; Ogan K
  • Assessment of basic human performance resources predicts performance of ureteroscopy.
    Am J Surg Volume: 191 Page(s): 817 - 820
    06/01/2006 Authors: Matsumoto ED; Kondraske GV; Ogan K; Jacomides L; Wilhelm DM; Pearle MS; Cadeddu JA
  • Effect of multisite radiofrequency ablation on porcine renal function.
    J Endourol Volume: 20 Page(s): 278 - 280
    04/01/2006 Authors: Duchene DA; Johnson DB; Jacomides L; Ogan K; Sagalowsky AI; Cadeddu JA
  • Renal tumor radiofrequency ablation.
    Minerva Urol Nefrol Volume: 57 Page(s): 261 - 269
    12/01/2005 Authors: Slabaugh TK; Ogan K
  • Report of aggressive renal cell carcinoma in two patients with von Hippel-Lindau disease.
    Urology Volume: 66 Page(s): 658
    09/01/2005 Authors: Healy KA; Hood N; Ogan K
  • Nonsurgical management of urolithiasis: an overview of expulsive therapy.
    J Endourol Volume: 19 Page(s): 759 - 767
    09/01/2005 Authors: Healy KA; Ogan K
  • Effect of cranberry juice consumption on urinary stone risk factors.
    J Urol Volume: 174 Page(s): 590 - 594
    08/01/2005 Authors: Gettman MT; Ogan K; Brinkley LJ; Adams-Huet B; Pak CYC; Pearle MS
  • Randomized comparison of standard laparoscopic trainer to novel, at-home, low-cost, camera-less laparoscopic trainer.
    Urology Volume: 66 Page(s): 50 - 54
    07/01/2005 Authors: Sharpe BA; MacHaidze Z; Ogan K
  • Monitoring radiofrequency renal lesions in real time using contrast-enhanced ultrasonography: a porcine model.
    J Endourol Volume: 19 Page(s): 579 - 583
    06/01/2005 Authors: Slabaugh TK; Machaidze Z; Hennigar R; Ogan K
  • Prospective, randomized trial comparing shock wave lithotripsy and ureteroscopy for lower pole caliceal calculi 1 cm or less.
    J Urol Volume: 173 Page(s): 2005 - 2009
    06/01/2005 Authors: Pearle MS; Lingeman JE; Leveillee R; Kuo R; Preminger GM; Nadler RB; Macaluso J; Monga M; Kumar U; Dushinski J
  • Molecular classification of renal tumors by gene expression profiling.
    J Mol Diagn Volume: 7 Page(s): 206 - 218
    05/01/2005 Authors: Schuetz AN; Yin-Goen Q; Amin MB; Moreno CS; Cohen C; Hornsby CD; Yang WL; Petros JA; Issa MM; Pattaras JG
  • Short-term efficacy of temperature-based radiofrequency ablation of small renal tumors.
    Urology Volume: 65 Page(s): 877 - 881
    05/01/2005 Authors: Matsumoto ED; Johnson DB; Ogan K; Trimmer C; Sagalowsky A; Margulis V; Cadeddu JA
  • Molecular basis for poor prognosis in renal cancer
    Volume: 173 Page(s): 102 - 102
    04/01/2005 Authors: Kraft K; Young AN; Ogan K; Issa MM; Marshall FF; Ritenour C; Petros JA
  • Pro-oxidant enzyme expression in renal and prostate cancers
    Volume: 173 Page(s): 103 - 103
    04/01/2005 Authors: Fernandez-Golarz CP; Arnold RS; Boone D; Young AN; Amin MB; Moreno C; Marshall FF; Ogan K; Petros JA
  • Virtual ureteroscopy predicts ureteroscopic proficiency of medical students on a cadaver.
    J Urol Volume: 172 Page(s): 667 - 671
    08/01/2004 Authors: Ogan K; Jacomides L; Shulman MJ; Roehrborn CG; Cadeddu JA; Pearle MS
  • The radiographic evolution of radio frequency ablated renal tumors.
    J Urol Volume: 172 Page(s): 45 - 48
    07/01/2004 Authors: Matsumoto ED; Watumull L; Johnson DB; Ogan K; Taylor GD; Josephs S; Cadeddu JA
  • Ureteral replacement using small-intestinal submucosa and a collagen inhibitor in a porcine model.
    J Endourol Volume: 18 Page(s): 507 - 511
    06/01/2004 Authors: Duchene DA; Jacomides L; Ogan K; Lindberg G; Johnson BD; Pearle MS; Cadeddu JA
  • Use of a virtual reality simulator for ureteroscopy training.
    J Urol Volume: 171 Page(s): 320 - 323
    01/01/2004 Authors: Jacomides L; Ogan K; Cadeddu JA; Pearle MS
  • Assessment of basic human performance resources predicts the performance of virtual ureterorenoscopy.
    J Urol Volume: 171 Page(s): 80 - 84
    01/01/2004 Authors: Johnson DB; Kondraske GV; Wilhelm DM; Jacomides L; Ogan K; Pearle MS; Cadeddu JA
  • Sensitivity of chest fluoroscopy compared with chest CT and chest radiography for diagnosing hydropneumothorax in association with percutaneous nephrostolithotomy.
    Urology Volume: 62 Page(s): 988 - 992
    12/01/2003 Authors: Ogan K; Corwin TS; Smith T; Watumull LM; Mullican MA; Cadeddu JA; Pearle MS
  • Photodynamic therapy for refractory superficial bladder cancer: long-term clinical outcomes of single treatment using intravesical diffusion medium.
    J Endourol Volume: 17 Page(s): 633 - 639
    10/01/2003 Authors: Manyak MJ; Ogan K
  • Assessment of basic human performance resources predicts operative performance of laparoscopic surgery.
    J Am Coll Surg Volume: 197 Page(s): 489 - 496
    09/01/2003 Authors: Gettman MT; Kondraske GV; Traxer O; Ogan K; Napper C; Jones DB; Pearle MS; Cadeddu JA
  • Nephrectomy after radiofrequency ablation-induced ureteropelvic junction obstruction: potential complication and long-term assessment of ablation adequacy.
    Urology Volume: 62 Page(s): 351 - 352
    08/01/2003 Authors: Johnson DB; Saboorian MH; Duchene DA; Ogan K; Cadeddu JA
  • Laparoscopic radical nephrectomy: oncologic efficacy.
    Urol Clin North Am Volume: 30 Page(s): 543 - 550
    08/01/2003 Authors: Ogan K; Cadeddu JA; Stifelman MD
  • Infrared thermography and thermocouple mapping of radiofrequency renal ablation to assess treatment adequacy and ablation margins.
    Urology Volume: 62 Page(s): 146 - 151
    07/01/2003 Authors: Ogan K; Roberts WW; Wilhelm DM; Bonnell L; Leiner D; Lindberg G; Kavoussi LR; Cadeddu JA
  • Sutureless laparoscopic heminephrectomy using laser tissue soldering.
    J Endourol Volume: 17 Page(s): 295 - 300
    06/01/2003 Authors: Ogan K; Jacomides L; Saboorian H; Koeneman K; Li Y; Napper C; Hoopman J; Pearle MS; Cadeddu JA
  • Feasibility of laparoscopic partial nephrectomy using pledgeted compression sutures for hemostasis.
    J Endourol Volume: 17 Page(s): 223 - 227
    05/01/2003 Authors: Wilhelm DM; Ogan K; Saboorian MH; Napper C; Pearle MS; Cadeddu JA
  • Laparoscopic application of radio frequency energy enables in situ renal tumor ablation and partial nephrectomy.
    J Urol Volume: 169 Page(s): 49 - 53
    01/01/2003 Authors: Jacomides L; Ogan K; Watumull L; Cadeddu JA
  • Oops we got in the chest: fluoroscopic chest tube insertion for hydrothorax after percutaneous nephrostolithotomy.
    Urology Volume: 60 Page(s): 1098 - 1099
    12/01/2002 Authors: Ogan K; Pearle MS
  • Percutaneous radiofrequency ablation of renal tumors: technique, limitations, and morbidity.
    Urology Volume: 60 Page(s): 954 - 958
    12/01/2002 Authors: Ogan K; Jacomides L; Dolmatch BL; Rivera FJ; Dellaria MF; Josephs SC; Cadeddu JA
  • Laparoscopic partial nephrectomy with a diode laser: porcine results.
    J Endourol Volume: 16 Page(s): 749 - 753
    12/01/2002 Authors: Ogan K; Wilhelm D; Lindberg G; Lotan Y; Napper C; Hoopman J; Pearle MS; Cadeddu JA
  • Minimally invasive management of the small renal tumor: review of laparoscopic partial nephrectomy and ablative techniques.
    J Endourol Volume: 16 Page(s): 635 - 643
    11/01/2002 Authors: Ogan K; Cadeddu JA
  • Assessment of basic endoscopic performance using a virtual reality simulator.
    J Am Coll Surg Volume: 195 Page(s): 675 - 681
    11/01/2002 Authors: Wilhelm DM; Ogan K; Roehrborn CG; Cadeddu JA; Pearle MS
  • Re: The uncertainty of radio frequency treatment of renal cell carcinoma: findings at immediate and delayed nephrectomy.
    J Urol Volume: 168 Page(s): 2128
    11/01/2002 Authors: Ogan K; Cadeddu JA
  • Laparoscopic versus open retroperitoneal lymph node dissection: a cost analysis.
    J Urol Volume: 168 Page(s): 1945 - 1949
    11/01/2002 Authors: Ogan K; Lotan Y; Koeneman K; Pearle MS; Cadeddu JA; Rassweiler J
  • Re: Percutaneous radio frequency ablation of small renal tumors: initial results.
    J Urol Volume: 168 Page(s): 660
    08/01/2002 Authors: Ogan K; Cadeddu JA
  • Radio frequency ablation induced acute renal failure.
    J Urol Volume: 168 Page(s): 186
    07/01/2002 Authors: Ogan K; Cadeddu JA; Sagalowsky AI
  • Clinical use of the holmium: YAG laser in laparoscopic partial nephrectomy.
    J Endourol Volume: 16 Page(s): 289 - 292
    06/01/2002 Authors: Lotan Y; Gettman MT; Ogan K; Baker LA; Cadeddu JA
  • Parental preferences in the management of vesicoureteral reflux.
    J Urol Volume: 166 Page(s): 240 - 243
    07/01/2001 Authors: Ogan K; Pohl HG; Carlson D; Belman AB; Rushton HG
  • Antimicrobial mesh versus vaginal wall sling: a comparative outcomes analysis.
    J Urol Volume: 163 Page(s): 1829 - 1834
    06/01/2000 Authors: Choe JM; Ogan K; Battino BS
  • Antibacterial mesh sling: a prospective outcome analysis.
    Urology Volume: 55 Page(s): 515 - 520
    04/01/2000 Authors: Choe JM; Ogan K; Bennett S
  • Gonadotropin releasing hormone analogue antiandrogen failure secondary to a pituitary adenoma.
    J Urol Volume: 160 Page(s): 497 - 498
    08/01/1998 Authors: Ogan K; Berger M; Ball R
  • Determination of vinca alkaloids in human plasma by liquid chromatography/atmospheric pressure chemical ionization mass spectrometry.
    Cancer Chemother Pharmacol Volume: 39 Page(s): 286 - 290
    01/01/1997 Authors: Ramrez J; Ogan K; Ratain MJ
  • Genomic Mapping of Primary Unifocal and Multifocal Renal Cell Carcinoma

    Authors: Obeng RC; Lorentz A; Alqassab U; Laganosky D; Keith C; Lian F; Ogan K; Master VA; Pattaras JG; Rossi M
  • Genomic Mapping of Primary Unifocal and Multifocal Renal Cell Carcinoma

    Authors: Obeng RC; Lorentz A; Alqassab U; Laganosky D; Keith C; Lian F; Ogan K; Master VA; Pattaras JG; Rossi M
Read more publications Fewer publications
Directory
  • Faculty Profiles
Emory University Homepage

Contact & Location

Emory University School of Medicine
100 Woodruff Circle
Atlanta, GA  30322 USA
  • Contact Us
  • Maps & Directions
  • Careers

Information For

  • Alumni
  • Faculty & Staff
  • Patients
  • Residents & Fellows
  • Students
Support the School of Medicine School of Medicine Intranet
facebook facebook twitter twitter linkedin linkedin instagram instagram youtube youtube
© 2025 Emory University
  • Privacy Policy
  • Emergency Information
  • EEO Employer-Disability/Veteran Statements